White Paper: Enhancing Patient Access with Early Access Programs

Design and Implementation Recommendations

Published on:
December 3, 2021
Written by:
Nerea Blanqué-Catalina, Luis Culla, Marie-Aude Ohresser, and Romain Finas

Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with a high unmet medical need before their commercialization.

Pre-launch strategies aim to address public health issues and to bring significant benefits to pharmaceutical companies, patients, and physicians. Such strategies aim to respond to regulatory delays, generate more KOL engagement, and enhance future P&R negotiations.

Download this white paper “Enhancing Patient Access with Early Access Programs: Design and Implementation Recommendations” in order to:

  • understand the complexity of launching EAPs
  • discover EAPs benefits
  • learn about the related challenges and ways to overcome them

Download your copy of "Enhancing Patient Access with Early Access Programs" white paper

Related news

Market Access
Multimedia January 19, 2022
Alira Health’s Transformation Talks: Early Access Programs: Why and How?
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives and the main recommendations(...)
Market Access
Multimedia December 16, 2021
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next. 
Market Access
Events November 24, 2021
Event: ISPOR Europe 2021
Join Alira Health experts at virtual ISPOR.
Market Access
Events November 9, 2021
Event: National Forum for Innovation in Health Sciences 2021
Join the Alira Health team at National Forum for Innovation in Health Sciences 2021 on November 17.
Market Access
Events November 2, 2021
Event: Eurobiomed: US Webinar Cycle: #2 Market Access & Regulatory Aspects
Join Alira Health's Director, Market Access, Pepi Hurtato, PhD, for an exclusive webinar session.
Market Access
Publications September 28, 2021
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Digital Health Market Access
Publications April 20, 2021
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.